"Dry Powder Inhalers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A device that delivers medication to the lungs in the form of a dry powder.
Descriptor ID |
D058995
|
MeSH Number(s) |
E07.605.500
|
Concept/Terms |
Dry Powder Inhalers- Dry Powder Inhalers
- Dry Powder Inhaler
- Inhaler, Dry Powder
- Inhalers, Dry Powder
- Powder Inhaler, Dry
- Powder Inhalers, Dry
|
Below are MeSH descriptors whose meaning is more general than "Dry Powder Inhalers".
Below are MeSH descriptors whose meaning is more specific than "Dry Powder Inhalers".
This graph shows the total number of publications written about "Dry Powder Inhalers" by people in this website by year, and whether "Dry Powder Inhalers" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2010 | 1 | 0 | 1 |
2011 | 0 | 1 | 1 |
2013 | 0 | 1 | 1 |
2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dry Powder Inhalers" by people in Profiles.
-
Efficacy and safety of inhaled dry-powder mannitol in adults with cystic fibrosis: An international, randomized controlled study. J Cyst Fibros. 2021 11; 20(6):1003-1009.
-
Inhaled alpha 1-antitrypsin: gauging patient interest in a new treatment. COPD. 2013 Aug; 10(4):411-5.
-
Long-term inhaled dry powder mannitol in cystic fibrosis: an international randomized study. Am J Respir Crit Care Med. 2012 Mar 15; 185(6):645-52.
-
Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial. J Cyst Fibros. 2011 Jan; 10(1):54-61.